GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4)

Company

Addex Therapeutics Ltd.

Filed

April 10, 2023

Accession Number

0001072613-23-000298